DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Ku GY, Yuan J, Page DB. et al.
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: Lymphocyte count after 2 doses correlates with survival.
Cancer 2010;
116: 1767-1775
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.